Page last updated: 2024-11-06

mitomycin and Dysphonia

mitomycin has been researched along with Dysphonia in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Dysphonia: Difficulty and/or pain in PHONATION or speaking.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Echternach, M1
Arndt, S1
Mattern, D1
Maier, W1
Richter, B1

Other Studies

1 other study available for mitomycin and Dysphonia

ArticleYear
Recurrent laryngeal metastasis of a malignant melanoma: surgical therapy with the first application of mitomycin C.
    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale, 2009, Volume: 38, Issue:1

    Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Combined Modality Therapy; Dysphonia; Female; Human

2009